Regulacje i polityka gospodarcza · 12/11/2008
NIH to Grant Exclusive License for Non-Invasive Diabetes Diagnostics
The National Institutes of Health is considering granting an exclusive worldwide license to Eyelight Diagnostics, Inc. for non-invasive diabetes diagnostics, using patented technologies for identifying individuals at risk for diabetes and measuring optical properties.